Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2016 / Article
Special Issue

Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects

View this Special Issue

Review Article | Open Access

Volume 2016 |Article ID 3578368 | https://doi.org/10.1155/2016/3578368

Katarzyna Licznerska, Bożena Nejman-Faleńczyk, Sylwia Bloch, Aleksandra Dydecka, Gracja Topka, Tomasz Gąsior, Alicja Węgrzyn, Grzegorz Węgrzyn, "Oxidative Stress in Shiga Toxin Production by Enterohemorrhagic Escherichia coli", Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 3578368, 8 pages, 2016. https://doi.org/10.1155/2016/3578368

Oxidative Stress in Shiga Toxin Production by Enterohemorrhagic Escherichia coli

Academic Editor: Luciano Saso
Received29 Jul 2015
Accepted30 Sep 2015
Published20 Dec 2015


Virulence of enterohemorrhagic Escherichia coli (EHEC) strains depends on production of Shiga toxins. These toxins are encoded in genomes of lambdoid bacteriophages (Shiga toxin-converting phages), present in EHEC cells as prophages. The genes coding for Shiga toxins are silent in lysogenic bacteria, and prophage induction is necessary for their efficient expression and toxin production. Under laboratory conditions, treatment with UV light or antibiotics interfering with DNA replication are commonly used to induce lambdoid prophages. Since such conditions are unlikely to occur in human intestine, various research groups searched for other factors or agents that might induce Shiga toxin-converting prophages. Among other conditions, it was reported that treatment with H2O2 caused induction of these prophages, though with efficiency significantly lower relative to UV-irradiation or mitomycin C treatment. A molecular mechanism of this phenomenon has been proposed. It appears that the oxidative stress represents natural conditions provoking induction of Shiga toxin-converting prophages as a consequence of H2O2 excretion by either neutrophils in infected humans or protist predators outside human body. Finally, the recently proposed biological role of Shiga toxin production is described in this paper, and the “bacterial altruism” and “Trojan Horse” hypotheses, which are connected to the oxidative stress, are discussed.

1. Introduction: Enterohemorrhagic Escherichia coli Strains and Shiga Toxin-Converting Phages

Escherichia coli is a bacterial species commonly known as a commensal occurring in the mammalian intestine [1]. This is true in most cases; however, some E. coli strains are capable of causing disease in humans. One example of pathogenic E. coli is a series of strains called Shiga toxin-producing E. coli (STEC) [2, 3].

Among STEC strains (defined as E. coli producing Shiga toxins), the most dangerous for humans is the subset classified as enterohemorrhagic Escherichia coli (EHEC, defined as E. coli causing bloody diarrhea) [2, 3]. Infection of humans by EHEC strains causes hemorrhagic colitis (HC) and in some patients it may result in various complications, including the most severe of them, the hemolytic-uremic syndrome (HUS) [2]. The most common symptoms of this syndrome are acute renal failure, anemia, and thrombocytopenia; however, other organs such as lung, pancreas, and heart may also be affected [4]. Furthermore, some patients suffer from the disorders of the central nervous system [4].

The main virulence factors causing EHEC-mediated HUS are Shiga toxins, produced by the infecting bacteria. These toxins are hexameric proteins, composed of a single A-subunit and five identical B subunits [5]. The main receptor, called Gb3 and occurring on the surface of many types of eukaryotic cells, is recognized by the B-subunits. The toxin enters cells by endocytosis, which is followed by its retrograde transport from the early endosome through the Golgi-apparatus and to the endoplasmic reticulum. The specific proteolytic cleavage of the A-subunit results in the release of the A1 polypeptide from the A2 fragment attached to the B pentamer. A1 is the actual toxin that is translocated from the ER to the cytoplasm [6, 7]. The Shiga toxin A1 polypeptide is an N-glycosidase that depurinates a single adenine residue (A4324) within the α-sarcin/ricin loop of the 28S rRNA [8, 9]. This modification results in an inhibition of amino-acyl-tRNA binding to the ribosome and cessation of protein synthesis, which leads to cell death [5].

Since cattle are resistant to Shiga toxins, due to the lack of the Gb3 receptor, they serve as a natural reservoir of STEC strains. However, any cattle-derived products contaminated by STEC, and particularly EHEC, may cause severe human infections, occurring usually as outbreaks. A few years ago (in 2011) such an outbreak took place in Germany, where over 4,000 patients developed severe symptoms and 54 of them died [1015]. Contaminated fenugreek and lentil sprouts were recognized as the source of the infection [13], indicating that unwashed or improperly washed vegetables, especially those coming from the so-called “ecological farming” where only natural fertilizers (including those coming from cattle) are used, may be a significant source of such outbreaks. In that case, the strain of the O104:H4 serotype, which caused the outbreak, had a combination of virulence factors characteristic of enteroaggregative E. coli (EAEC) and EHEC [12, 14]. The high virulence of this particular strain could be ascribed to enhanced adhesion, survival adjustment, antibiotic resistance, and Shiga toxin production [12].

Interestingly, genes coding for Shiga toxins (stx genes) are located in genomes of prophages rather than in actual bacterial genome [16, 17]. Bacteriophages bearing the stx genes, called Shiga toxin-converting phages or Stx phages, can lysogenize E. coli strains making them STEC. All Stx phages described to date belong to the family of lambdoid phages, viruses having genomes organized in a manner similar to that found in bacteriophage λ [17]. The genome of a lambdoid phage consists of blocks of genes coding for proteins responsible for specific functions. This makes recombination and exchange of genes between various phages relatively easy and leads to mosaicism of genomes of lambdoid phages [18]. In genomes of Shiga toxin-converting phages, the stx genes are present between the antiterminator gene and the genes coding for proteins causing cell lysis (Figure 1(a)).

As long as the Stx bacteriophage is present in the E. coli host as a prophage, vast majority of its genes, including stx genes, are silent due to the repression caused by the phage-encoded cI protein [1921]. Under such conditions, Shiga toxin is not produced. Effective expression of stx genes, together with all genes required for lytic development of the bacteriophage, occurs only after prophage induction, though Shiga toxin 1 may also be produced under conditions of low iron levels due to the presence of the Fe-sensitive promoter upstream of the stx1 locus [17, 20]. The prophage induction occurs generally due to activation of the bacterial SOS response which is a defensive mechanism provoked by any conditions causing appearance of single-stranded DNA fragments. The RecA protein recognizes such fragments and is activated to stimulate the self-cleavage of the LexA repressor (bearing the peptidase domain in its structure), which under normal conditions inhibits expression of the SOS regulon (Figure 1(b)). However, the phage cI repressor resembles LexA (Figure 2) and it is also degraded under the SOS stress response, causing derepression of bacteriophage promoters, excision of the prophage, and subsequent lytic development of the virus. Importantly, in the case of Stx phages, expression of the stx genes proceeds together with other phage genes [17, 20, 21] (Figure 1(a)). It is worth mentioning that RecA-independent induction of Shiga toxin-converting prophages by chelating agents, like EDTA, has also been reported [22]. In conclusion, production of Shiga toxins requires induction of Stx prophages, caused by either any stress conditions provoking the SOS response or by chelating agents.

Under laboratory conditions, induction of lambdoid prophages is relatively easy, and standard methods for the efficient induction include UV-irradiation and treatment with antibiotics that interfere with bacterial DNA replication, like mitomycin C [20, 21]. Such treatments lead to prophage excision in a large fraction, if not most, of lysogenic cells in a bacterial population. Nevertheless, when infection of humans by EHEC is analyzed, one should consider prophage induction conditions which can naturally occur in human intestine. Obviously UV-irradiation is very unlikely there, and high concentrations of antibiotics may be administered only to patients subjected to intensive therapy, while symptoms of EHEC infection appear also in nontreated persons. Moreover, other inducers of prophage excision, like EDTA [22], irradiation with 60Co [27], or high hydrostatic pressure [28], are also unlikely to occur in the human gut. Therefore, an important question arose: what are factors or agents that can induce Shiga toxin-converting prophages in EHEC-infected human intestine? Understanding the mechanism of stimulation of Shiga toxin production might lead to development of novel methods for prevention or treatment of EHEC-caused diseases, as well as deciphering a biological role for maintaining the Stx prophages in bacterial genomes.

2. Hydrogen Peroxide as an Inducer of Shiga Toxin-Converting Prophages

There were various attempts to find conditions which both induce Stx prophages and are likely to occur in the human gut. Different conditions, factors, and agents (including high and low temperatures, high salt concentrations, chelators, 60Co, high hydrostatic pressure, nitric oxide, and starvation) were tested, and the results of these studies have been summarized [17]. Most of the tested conditions either did not induce lambdoid prophages or were unlikely to occur in human intestine.

Under conditions of bacterial infection, including infection of the human gut, neutrophils are the first cells of the immune system which attack the pathogens. Among other bactericidal mediators, neutrophils excrete hydrogen peroxide to weaken bacterial cells. This oxidative stress-inducing agent is dangerous for bacteria that are much more sensitive to it than eukaryotic cells. However, it was demonstrated that such an action of neutrophils enhances production of Shiga toxins by EHEC strains [29]. Subsequent studies indicated that hydrogen peroxide, when added to cultures of bacteria lysogenic for various Shiga toxin-converting phages, is a potent inducer of the prophages [30]. This was true for bacteriophage λ as well as for different Stx phages. Moreover, the prophage induction was accompanied by synthesis of considerable amounts of the fusion protein, encoded by a gene located in the place of the natural locus [30]. Very similar results were obtained when natural isolate of EHEC was tested instead of laboratory strains. Again, hydrogen peroxide-mediated induction of the Stx prophage and efficient production of Shiga toxin were observed [31]. Therefore, the oxidative stress, mediated by hydrogen peroxide, leads to stimulation of expression of genes. Since such conditions can occur in human intestine, the oxidative stress is a likely candidate for a natural inducer of Shiga toxin-converting prophages.

An interesting observation in studies on both laboratory Stx lysogens and natural isolates of EHEC was that the maximal efficiency of prophage induction occurred at a final concentration of 3 mM, and further increases in concentrations caused a decrease in induction efficiency [30, 31]. Moreover, while prophage induction by UV-irradiation or mitomycin C caused a lysis of bacterial cultures in a few hours, no such phenomenon could be detected after treatment with hydrogen peroxide [30]. Subsequent calculations of the efficiency of prophage induction have shown that while low concentration (1 μg/mL) of mitomycin C caused initiation of the lytic phage development in about 10–30% of cells (depending on the kind of the Stx phage), the value of this parameter was as low as 0.03–1.6% at the optimal (for prophage induction, i.e., 3 mM) concentration of hydrogen peroxide [32]. Therefore, in -treated lysogenic bacteria, only a very small fraction of cells (usually less than 1%) is induced for prophage excision and subsequent lytic development. Since the rest of bacterial population in the culture can grow and propagate due to resistance to infection by the same phage as the prophage present inside the cell, it is not possible to observe culture lysis.

Another question was what is the mechanism causing the low efficiency of prophage induction under conditions of oxidative stress? Studies on bacteriophage λ, the best known representative of lambdoid phages, indicated the factor responsible for such a phenomenon. Since DNA sequences of the regulatory regions of λ and Stx phages are very similar [33], one can suppose that the processes occurring in these phages are generally the same.

It was demonstrated that the prophage induction by hydrogen peroxide is over 100 times more effective in cells with deletion of the oxyR gene than in wild-type control [26]. The OxyR protein is a transcription factor acting as a major regulator of the oxidative stress [34]. In the phage DNA region responsible for the control of maintenance of the prophage, there are 3 sites for binding of the cI repressor, called , , and (Figure 3). Binding of the cI protein to and represses , the major promoter for expression of genes required during the lytic development, but at the same time stimulates transcription of the cI gene from the promoter. At high concentrations of cI, this protein can bind also to which causes a repression of its own promoter [20] (Figure 4).

Detailed molecular studies indicated that OxyR can bind specifically to the region of the - promoters (introduction of mutations to the putative OxyR-binding site abolished interactions of this protein with DNA), though with a weaker affinity than to its own promoter [26]. Interestingly, in the presence of OxyR, the cI protein interactions with , were enhanced, while binding of this repressor to was impaired. These results suggested that OxyR might stimulate repression of and activation of but at the same time downregulate repression of [26]. This would lead to a considerably more efficient maintenance of the prophage due to more efficient blocking of the promoter by abundant cI. Indeed, studies with gene fusions showed that while under normal growth conditions (when OxyR is inactive) the activity of the promoter was similar in both oxyR+ and ΔoxyR strains, the oxidative stress conditions (treatment of cells with which activates OxyR) caused enhanced transcription from in wild-type bacteria and decreased in the ΔoxyR mutant [26]. Therefore, it appears that the OxyR protein is responsible for the low efficiency of prophage induction caused under conditions of the oxidative stress (Figure 4).

3. The Oxidative Stress and Biological Role of Shiga Toxin Production by STEC

There is an intriguing question regarding the biological role of Shiga toxin production by STEC strains. As described in preceding sections, expression of stx genes is effective only after Shiga toxin-converting prophage induction. However, this also results in subsequent lytic development of the bacteriophage and eventual death of the host cell. Thus, what can be a benefit for the bacterium from production of Shiga toxin while it is linked to its death? On the other hand, if toxin production was not beneficial for E. coli, one should expect a positive selection of lysogenic bacteria with mutations causing deficiency in prophage induction and thus elimination of STEC cells from the bacterial population. Since this is not the case, it should be beneficial for STEC to produce Shiga toxin.

It was suggested that STEC virulence in humans may be coincidental with the biological role for Shiga toxin being unrelated to human infection [35]. This hypothesis assumed that synthesis of Shiga toxins by STEC may enhance survival of bacteria in food vacuoles of protozoan predators. Interestingly, such a phenomenon was demonstrated experimentally [36]. Moreover, a bacterivorous, protozoan predator, Tetrahymena thermophila, was shown to be killed when cocultured with bacteria lysogenic with Stx bacteriophage [37]. However, this killing did not occur in the presence of catalase, an enzyme responsible for hydrogen peroxide breakdown [37]. In fact, Tetrahymena produces to damage bacterial cells during attack by this predator [37]. This may be a successful predatory strategy in the case of the vast majority of bacteria; however, if STEC cells are being attacked, Shiga toxin-converting prophages are induced due to action of hydrogen peroxide (as demonstrated experimentally [30, 31]), Shiga toxin is produced, and after toxin release from E. coli due to phage-mediated cell lysis, it kills the predator. The crucial point of such a defensive bacterial strategy is a low effective prophage induction by which has also been shown [30, 31]. Therefore, of the total STEC population, only 1% or less is lost for production of Shiga toxin (which is enough to produce relatively large amounts of the toxin, sufficient to kill the predator) while the rest of bacteria are saved. When STEC infects human intestine, neutrophils’ action is similar to that of protist predators, and is produced to kill bacteria [38], but the effects are analogous to the Tetrahymena-STEC interplay. The hypothesis on such an “bacterial altruism” has been proposed independently by two groups [17, 39], and detailed analyses of the literature indicated that the predicted scenario may be true [32]. Moreover, the hypothesis has been further confirmed by recent discoveries that STEC strains are more resistant to the impact of grazing protists than E. coli devoid of the stx genes [40] and that bacteriophage-mediated lysis of STEC is necessary for killing of protist cells by Shiga toxin, since the toxin released as a consequence of digestion of bacteria by Tetrahymena is harmless to it [41]. The latter finding was the argument to call the STEC cells a “Trojan Horse,” carrying genes encoding the toxin into target organisms [42].

4. Concluding Remarks

The oxidative stress plays a pivotal role in the production of Shiga toxins in cells of enterohemorrhagic Escherichia coli (EHEC) infecting human intestine, as well as in response to the attack of predator protists. In both cases, hydrogen peroxide is excreted by eukaryotic cells (either protist predators or neutrophils in an infected organism) to weaken bacteria which is a successful strategy against most prokaryotes; however, EHEC strains are lysogenic for Shiga toxin-converting prophages, and stimulates their induction. This leads to the switch to lytic development and production of the toxin. It appears that Shiga toxin-producing bacteria use the specific strategy of “bacterial altruism,” based on the OxyR-mediated low efficiency of prophage induction during the oxidative stress. As a consequence, only a small fraction of bacterial cells is destroyed due to prophage induction, which is nevertheless sufficient to produce relatively large amounts of Shiga toxins able to kill eukaryotic cells. In this way the rest of the E. coli population can survive the attack of the predator or neutrophils.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


This work was supported by National Science Center (Poland) Grant no. 2013/09/B/NZ2/02366 to Alicja Węgrzyn.


  1. D. L. Hartl and D. E. Dykhuizen, “The population genetics of Escherichia coli,” Annual Review of Genetics, vol. 18, pp. 31–68, 1984. View at: Publisher Site | Google Scholar
  2. C. L. Gyles, “Shiga toxin-producing Escherichia coli: an overview,” Journal of Animal Science, vol. 85, supplement 13, pp. E45–E62, 2007. View at: Publisher Site | Google Scholar
  3. J. M. Hunt, “Shiga toxin-producing Escherichia coli (STEC),” Clinics in Laboratory Medicine, vol. 30, no. 1, pp. 21–45, 2010. View at: Publisher Site | Google Scholar
  4. S. Razzaq, “Hemolytic uremic syndrome: an emerging health risk,” American Family Physician, vol. 74, no. 6, pp. 991–998, 2006. View at: Google Scholar
  5. D. Law, “Virulence factors of Escherichia coli O157 and other Shiga toxin- producing E. coli,” Journal of Applied Microbiology, vol. 88, no. 5, pp. 729–745, 2000. View at: Publisher Site | Google Scholar
  6. P. LaPointe, X. Wei, and J. Gariépy, “A role for the protease-sensitive loop region of Shiga-like toxin 1 in the retrotranslocation of its A1 domain from the endoplasmic reticulum lumen,” The Journal of Biological Chemistry, vol. 280, no. 24, pp. 23310–23318, 2005. View at: Publisher Site | Google Scholar
  7. P. J. Tam and C. A. Lingwood, “Membrane-cytosolic translocation of verotoxin A1 subunit in target cells,” Microbiology, vol. 153, no. 8, pp. 2700–2710, 2007. View at: Publisher Site | Google Scholar
  8. T. G. Obrig, T. P. Moran, and J. E. Brown, “The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis,” Biochemical Journal, vol. 244, no. 2, pp. 287–294, 1987. View at: Publisher Site | Google Scholar
  9. Y. Endo, K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi, “Site of action of a vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins,” European Journal of Biochemistry, vol. 171, no. 1-2, pp. 45–50, 1988. View at: Publisher Site | Google Scholar
  10. L. Beutin and A. Martin, “Outbreak of shiga toxin-producing Escherichia coli (STEC) O104:H4 infection in Germany causes a paradigm shift with regard to human pathogenicity of STEC strains,” Journal of Food Protection, vol. 75, no. 2, pp. 408–418, 2012. View at: Publisher Site | Google Scholar
  11. S. K. Bloch, A. Felczykowska, and B. Nejman-Falenczyk, “Escherichia coli O104:H4 outbreak—have we learnt a lesson from it?” Acta Biochimica Polonica, vol. 59, no. 4, pp. 483–488, 2012. View at: Google Scholar
  12. H. Karch, E. Denamur, U. Dobrindt et al., “The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak,” EMBO Molecular Medicine, vol. 4, no. 9, pp. 841–848, 2012. View at: Publisher Site | Google Scholar
  13. U. Buchholz, H. Bernard, D. Werber et al., “German outbreak of Escherichia coli O104:H4 associated with sprouts,” The New England Journal of Medicine, vol. 365, no. 19, pp. 1763–1770, 2011. View at: Publisher Site | Google Scholar
  14. A. Mellmann, D. Harmsen, C. A. Cummings et al., “Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology,” PLoS ONE, vol. 6, no. 7, Article ID e22751, 2011. View at: Publisher Site | Google Scholar
  15. D. Werber, G. Krause, C. Frank et al., “Outbreaks of virulent diarrheagenic Escherichia coli—are we in control?” BMC Medicine, vol. 10, article 11, 2012. View at: Publisher Site | Google Scholar
  16. H. E. Allison, “Stx-phages: drivers and mediators of the evolution of STEC and STEC-like pathogens,” Future Microbiology, vol. 2, no. 2, pp. 165–174, 2007. View at: Publisher Site | Google Scholar
  17. J. M. Łoś, M. Łoś, and G. Wegrzyn, “Bacteriophages carrying Shiga toxin genes: genomic variations, detection and potential treatment of pathogenic bacteria,” Future Microbiology, vol. 6, no. 8, pp. 909–924, 2011. View at: Publisher Site | Google Scholar
  18. B. K. Johansen, Y. Wasteson, P. E. Granum, and S. Brynestad, “Mosaic structure of Shiga-toxin-2-encoding phages isolated from Escherichia coli O157:H7 indicates frequent gene exchange between lambdoid phage genomes,” Microbiology, vol. 147, no. 7, pp. 1929–1936, 2001. View at: Publisher Site | Google Scholar
  19. M. Ptashne, A Genetic Switch, Phage Lambda Revisited, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 3rd edition, 2004.
  20. G. Węgrzyn and A. Węgrzyn, “Genetic switches during bacteriophage λ development,” Progress in Nucleic Acid Research and Molecular Biology, vol. 79, pp. 1–48, 2005. View at: Publisher Site | Google Scholar
  21. G. Wegrzyn, K. Licznerska, and A. Wegrzyn, “Phage λ-new insights into regulatory circuits,” Advances in Virus Research, vol. 82, pp. 155–178, 2012. View at: Publisher Site | Google Scholar
  22. L. Imamovic and M. Muniesa, “Characterizing RecA-independent induction of Shiga toxin2-encoding phages by EDTA treatment,” PLoS ONE, vol. 7, no. 2, Article ID e32393, 2012. View at: Publisher Site | Google Scholar
  23. A. P. Koudelka, L. A. Hufnagel, and G. B. Koudelka, “Purification and characterization of the repressor of the shiga toxin-encoding bacteriophage 933W: DNA binding, gene regulation, and autocleavage,” Journal of Bacteriology, vol. 186, no. 22, pp. 7659–7669, 2004. View at: Publisher Site | Google Scholar
  24. R. Serra-Moreno, J. Jofre, and M. Muniesa, “The CI repressors of Shiga toxin-converting prophages are involved in coinfection of Escherichia coli strains, which causes a down regulation in the production of Shiga toxin 2,” Journal of Bacteriology, vol. 190, no. 13, pp. 4722–4735, 2008. View at: Publisher Site | Google Scholar
  25. J. Ren, L. Wen, X. Gao, C. Jin, Y. Xue, and X. Yao, “DOG 1.0: illustrator of protein domain structures,” Cell Research, vol. 19, no. 2, pp. 271–273, 2009. View at: Publisher Site | Google Scholar
  26. M. Glinkowska, J. M. Łoś, A. Szambowska et al., “Influence of the Escherichia coli oxyR gene function on lambda prophage maintenance,” Archives of Microbiology, vol. 192, no. 8, pp. 673–683, 2010. View at: Publisher Site | Google Scholar
  27. T. Yamamoto, S. Kojio, I. Taneike, S. Nakagawa, N. Iwakura, and N. Wakisaka-Saito, “60Co irradiation of Shiga toxin (Stx)-producing Escherichia coli induces Stx phage,” FEMS Microbiology Letters, vol. 222, no. 1, pp. 115–121, 2003. View at: Publisher Site | Google Scholar
  28. A. Aertsen, D. Faster, and C. W. Michiels, “Induction of Shiga toxin-converting prophage in Escherichia coli by high hydrostatic pressure,” Applied and Environmental Microbiology, vol. 71, no. 3, pp. 1155–1162, 2005. View at: Publisher Site | Google Scholar
  29. P. L. Wagner, D. W. K. Acheson, and M. K. Waldor, “Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli,” Infection and Immunity, vol. 69, no. 3, pp. 1934–1937, 2001. View at: Publisher Site | Google Scholar
  30. J. M. Łoś, M. Łoś, G. Węgrzyn, and A. Węgrzyn, “Differential efficiency of induction of various lambdoid prophages responsible for production of Shiga toxins in response to different induction agents,” Microbial Pathogenesis, vol. 47, no. 6, pp. 289–298, 2009. View at: Publisher Site | Google Scholar
  31. J. M. Łoś, M. Łoś, A. Wȩgrzyn, and G. Wȩgrzyn, “Hydrogen peroxide-mediated induction of the Shiga toxin-converting lambdoid prophage ST2-8624 in Escherichia coli O157:H7,” FEMS Immunology and Medical Microbiology, vol. 58, no. 3, pp. 322–329, 2010. View at: Publisher Site | Google Scholar
  32. J. M. Loś, M. Loś, A. Wegrzyn, and G. Wegrzyn, “Altruism of Shiga toxin-producing Escherichia coli: recent hypothesis versus experimental results,” Frontiers in Cellular and Infection Microbiology, vol. 2, article 166, 2013. View at: Google Scholar
  33. B. Nejman, J. M. Łoś, M. Łoś, G. Wgrzyn, and A. Wgrzyn, “Plasmids derived from lambdoid bacteriophages as models for studying replication of mobile genetic elements responsible for the production of shiga toxins by pathogenic Escherichia coli strains,” Journal of Molecular Microbiology and Biotechnology, vol. 17, no. 4, pp. 211–220, 2009. View at: Publisher Site | Google Scholar
  34. S. M. Chiang and H. E. Schellhorn, “Regulators of oxidative stress response genes in Escherichia coli and their functional conservation in bacteria,” Archives of Biochemistry and Biophysics, vol. 525, no. 2, pp. 161–169, 2012. View at: Publisher Site | Google Scholar
  35. M. T. Brandl, “Fitness of human enteric pathogens on plants and implications for food safety,” Annual Review of Phytopathology, vol. 44, pp. 367–392, 2006. View at: Publisher Site | Google Scholar
  36. K. M. Steinberg and B. R. Levin, “Grazing protozoa and the evolution of the Escherichia coli O157:H7 Shiga toxin-encoding prophage,” Proceedings of the Royal Society B: Biological Sciences, vol. 274, no. 1621, pp. 1921–1929, 2007. View at: Publisher Site | Google Scholar
  37. W. Lainhart, G. Stolfa, and G. B. Koudelka, “Shiga toxin as a bacterial defense against a eukaryotic predator, Tetrahymena thermophila,” Journal of Bacteriology, vol. 191, no. 16, pp. 5116–5122, 2009. View at: Publisher Site | Google Scholar
  38. M. F. Tsan, K. H. Douglass, and P. A. McIntyre, “Hydrogen peroxide production and killing of Staphylococcus aureus by human polymorphonuclear leukocytes,” Blood, vol. 49, no. 3, pp. 437–444, 1977. View at: Google Scholar
  39. S. A. Mauro and G. B. Koudelka, “Shiga toxin: expression, distribution, and its role in the environment,” Toxins, vol. 3, no. 6, pp. 608–625, 2011. View at: Publisher Site | Google Scholar
  40. S. A. Mauro, H. Opalko, K. Lindsay, M. P. Colon, and G. B. Koudelka, “The microcosm mediates the persistence of shiga toxin-producing Escherichia coli in freshwater ecosystems,” Applied and Environmental Microbiology, vol. 79, no. 16, pp. 4821–4828, 2013. View at: Publisher Site | Google Scholar
  41. G. Stolfa and G. B. Koudelka, “Entry and killing of Tetrahymena thermophila by bacterially produced Shiga toxin,” mBio, vol. 4, no. 1, Article ID e00416-12, 2013. View at: Publisher Site | Google Scholar
  42. J. W. Arnold and G. B. Koudelka, “The Trojan Horse of the microbiological arms race: phage-encoded toxins as a defence against eukaryotic predators,” Environmental Microbiology, vol. 16, no. 2, pp. 454–466, 2014. View at: Publisher Site | Google Scholar

Copyright © 2016 Katarzyna Licznerska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles